Literature DB >> 8491759

Porokeratosis large skin lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility.

F Otsuka1, Y Umebayashi, S Watanabe, M Kawashima, S Hamanaka.   

Abstract

Porokeratosis (PK), an autosomal dominant inherited skin disorder, is known to develop malignant skin tumors on its skin lesions. Our recent literature survey has revealed that large PK skin lesions are frequently a precursor of malignant changes. In the study, large and small PK skin lesions were investigated in terms of histological features of the epidermis and of the cellular DNA content of epidermal cells. Large PK lesions frequently showed hypertrophic epidermis with many mitotic cells, while small lesions usually presented atrophic epidermis without such mitotic cells. Abnormal cells, like those containing hyperchromatic, large, and/or irregularly shaped nuclei, were present in the epidermis of both large and small lesions with a preponderance in the former over the latter. DNA polyploidy was seen more frequently in large PK lesions than in small ones. DNA index values were significantly higher in large lesions than in small ones. The histological features and DNA ploidy abnormalities probably reflect the higher proliferation and the greater potential for malignant changes of large PK skin lesions. Our study helps to explain the clinical evidence that large PK skin lesions are frequently a precursor of malignant skin tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491759     DOI: 10.1007/BF01218420

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Porokeratosis as a premalignant condition of the skin. Cytologic demonstration of abnormal DNA ploidy in cells of the epidermis.

Authors:  F Otsuka; A Shima; Y Ishibashi
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

2.  Chromosomal instability associated with susceptibility to malignant disease in patients with porokeratosis of Mibelli.

Authors:  A M Taylor; D G Harnden; E A Fairburn
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

3.  Porokeratosis--a mutant clonal keratosis of the epidermis. I. Histogenesis.

Authors:  R J Reed; P Leone
Journal:  Arch Dermatol       Date:  1970-03

4.  Disseminated porokeratosis accompanying multicentric Bowen's disease. Characterization of porokeratotic lesions progressing to Bowen's disease.

Authors:  F Otsuka; J Huang; K Sawara; A Asahina; Y Ishibashi
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

5.  Porokeratosis with large skin lesions. Histologic, cytologic and cytogenetic study of three cases.

Authors:  F Otsuka; R Watanabe; M Kawashima; Y Tomita; K Ohara; Y Ishibashi
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

6.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

7.  Chromosomal instability and cellular hypersensitivity to X-radiation of cultured fibroblasts derived from porokeratosis patients' skin.

Authors:  R Watanabe; Y Ishibashi; F Otsuka
Journal:  Mutat Res       Date:  1990-06       Impact factor: 2.433

8.  Cytogenetic studies in a patient with porokeratosis of Mibelli, multiple cancers and a forme fruste of Werner's syndrome.

Authors:  H Machino; Y Miki; T Teramoto; S Shiraishi; M S Sasaki
Journal:  Br J Dermatol       Date:  1984-11       Impact factor: 9.302

9.  Clonal chromosome abnormalities with preferential involvement of chromosome 3 in patients with porokeratosis of Mibelli.

Authors:  S Scappaticci; S Lambiase; G Orecchia; M Fraccaro
Journal:  Cancer Genet Cytogenet       Date:  1989-11

10.  Cultured skin fibroblasts from patients with porokeratosis are hypersensitive to the lethal effects of X-radiation.

Authors:  F Otsuka; R Watanabe; A Moro; H Ohkochi; Y Ishibashi
Journal:  Jpn J Cancer Res       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.